Cipla gains 5% on USFDA nod for generic cancer drug; set to launch in the US
Elara had already factored in approximately $20 million in revenue from gAbraxane in the US for FY26. While 3–4 generic players are currently active in the market and the overall size has eroded, Elara still believes Cipla has the potential to generate up to $50 million from the product.
Elara had already factored in approximately $20 million in revenue from gAbraxane in the US for FY26. While 3–4 generic players are currently active in the market and the overall size has eroded, Elara still believes Cipla has the potential to generate up to $50 million from the product.
What's Your Reaction?
FEDA-HQ
The Federation of Economic Development Association of India (F.E.D.A) holds the distinction of being India's most venerable umbrella organization. F.E.D.A focused on promoting economic growth in India. Economic development professionals throughout the state, along with individuals and companies in related economic development fields, work together with the F.E.D.A Members and Board of Federation to help positively influence country legislation and industrial growth. With cutting edge policy research and advisory to National and State governments on trade issues. F.E.D.A is one of the leading non-profit organizations with established credentials for enhancing economic development.
